Lavipharm S.A.
LAVI.AT
Get informed when a big investor buys or sells
+ FollowMarket Cap$257.87M
Close$
Share Statistics
| Market cap | $257.87 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $0.02 (1.32%) |
| Earnings per Share | $0.04 |
| Beta | 1.01 |
| Outstanding Shares | 169,458,000 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 44.41 |
|---|---|
| PEG | -534.59 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 17, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
March 3, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Lavipharm S.A.
306 employees
CEO: Telemaque Jean Lavidas Lavipharm S.A. is a company that specializes in the comprehensive lifecycle of pharmaceutical, dermocosmetic, and general healthcare products, from initial research and development to manufacturing, importation, marketing, and distributi...